348 related articles for article (PubMed ID: 28367092)
1. PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.
Zhao D; Wang W; Wang H; Peng H; Liu X; Guo W; Su G; Zhao Z
Int J Biol Sci; 2017; 13(3):276-285. PubMed ID: 28367092
[TBL] [Abstract][Full Text] [Related]
2. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
3. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
[TBL] [Abstract][Full Text] [Related]
4. GPR30 Alleviates Pressure Overload-Induced Myocardial Hypertrophy in Ovariectomized Mice by Regulating Autophagy.
Zhang S; Ma J; Wang X; Zhao D; Zhang J; Jiang L; Duan W; Wang X; Hong Z; Li Z; Liu J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674423
[TBL] [Abstract][Full Text] [Related]
5. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
6. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
7. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
Cui Y; Wang Y; Liu G
Pharm Biol; 2021 Dec; 59(1):1305-1313. PubMed ID: 34607503
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
[TBL] [Abstract][Full Text] [Related]
11. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
12. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
[TBL] [Abstract][Full Text] [Related]
13. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
Ha T; Li Y; Gao X; McMullen JR; Shioi T; Izumo S; Kelley JL; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
Free Radic Biol Med; 2005 Dec; 39(12):1570-80. PubMed ID: 16298682
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
16. Choline Inhibits Ischemia-Reperfusion-Induced Cardiomyocyte Autophagy in Rat Myocardium by Activating Akt/mTOR Signaling.
Hang P; Zhao J; Su Z; Sun H; Chen T; Zhao L; Du Z
Cell Physiol Biochem; 2018; 45(5):2136-2144. PubMed ID: 29533930
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
18. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway.
Sui Y; Yao H; Li S; Jin L; Shi P; Li Z; Wang G; Lin S; Wu Y; Li Y; Huang L; Liu Q; Lin X
J Mol Med (Berl); 2017 Mar; 95(3):311-322. PubMed ID: 27838742
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
20. YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI
Wan M; Yin K; Yuan J; Ma S; Xu Q; Li D; Gao H; Gou X
J Ethnopharmacol; 2022 Mar; 285():114835. PubMed ID: 34798161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
